DVSMX vs. NCLEX
DVSMX (Driehaus Small Cap Growth Fund) and NCLEX (Nicholas Limited Edition Fund) are both Small Cap Growth Equities funds. Over the past 5 years, DVSMX returned 7.87%/yr vs -1.50%/yr for NCLEX. Their correlation of 0.83 suggests significant overlap in exposure. DVSMX charges 0.99%/yr vs 0.85%/yr for NCLEX.
Performance
DVSMX vs. NCLEX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, DVSMX achieves a 21.18% return, which is significantly higher than NCLEX's -5.49% return.
DVSMX
- 1D
- 0.00%
- 1M
- 1.03%
- YTD
- 21.18%
- 6M
- 17.14%
- 1Y
- 52.56%
- 3Y*
- 24.83%
- 5Y*
- 7.87%
- 10Y*
- —
NCLEX
- 1D
- 2.05%
- 1M
- 2.35%
- YTD
- -5.49%
- 6M
- -7.59%
- 1Y
- -10.17%
- 3Y*
- 0.88%
- 5Y*
- -1.50%
- 10Y*
- 7.67%
DVSMX vs. NCLEX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
DVSMX Driehaus Small Cap Growth Fund | 21.18% | 16.66% | 27.44% | 18.93% | -34.12% | 18.41% | 63.95% | 40.29% | -8.71% |
NCLEX Nicholas Limited Edition Fund | -5.49% | -10.41% | 11.91% | 17.17% | -23.71% | 19.07% | 22.67% | 27.36% | -3.11% |
Correlation
The correlation between DVSMX and NCLEX is 0.54, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.54 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.73 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.80 |
Correlation (All Time) Calculated using the full available price history since May 9, 2018 | 0.83 |
Over the past year, the correlation between DVSMX and NCLEX has dropped to 0.54 - well below their long-term average of 0.83, suggesting their price drivers have been diverging.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
DVSMX vs. NCLEX — Risk / Return Rank
DVSMX
NCLEX
DVSMX vs. NCLEX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Driehaus Small Cap Growth Fund (DVSMX) and Nicholas Limited Edition Fund (NCLEX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| DVSMX | NCLEX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +2.60 | ||
| Sortino ratioReturn per unit of downside risk | +3.34 | ||
| Omega ratioGain probability vs. loss probability | 1.32 | 0.90 | +0.42 |
| Calmar ratioReturn relative to maximum drawdown | 3.37 | -0.53 | +3.91 |
| Martin ratioReturn relative to average drawdown | 12.48 | -1.05 | +13.53 |
Loading charts...
Drawdowns
DVSMX vs. NCLEX - Drawdown Comparison
The maximum DVSMX drawdown since its inception was -47.64%, roughly equal to the maximum NCLEX drawdown of -48.68%. Use the drawdown chart below to compare losses from any high point for DVSMX and NCLEX.
Loading charts...
Drawdown Indicators
| DVSMX | NCLEX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -47.64% | -48.68% | +1.04% |
Max Drawdown (1Y)Largest decline over 1 year | -15.39% | -21.36% | +5.97% |
Max Drawdown (3Y)Largest decline over 3 years | -34.77% | -28.50% | -6.27% |
Max Drawdown (5Y)Largest decline over 5 years | -47.64% | -28.50% | -19.14% |
Max Drawdown (10Y)Largest decline over 10 years | — | -35.79% | — |
Current DrawdownCurrent decline from peak | -2.39% | -20.93% | +18.54% |
Average DrawdownAverage peak-to-trough decline | -17.12% | -8.30% | -8.82% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.14% | 10.79% | -6.65% |
Volatility
DVSMX vs. NCLEX - Volatility Comparison
Driehaus Small Cap Growth Fund (DVSMX) has a higher volatility of 10.33% compared to Nicholas Limited Edition Fund (NCLEX) at 4.88%. This indicates that DVSMX's price experiences larger fluctuations and is considered to be riskier than NCLEX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| DVSMX | NCLEX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 10.33% | 4.88% | +5.45% |
Volatility (6M)Calculated over the trailing 6-month period | 21.28% | 12.57% | +8.71% |
Volatility (1Y)Calculated over the trailing 1-year period | 26.90% | 17.04% | +9.86% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 29.09% | 19.56% | +9.53% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 29.54% | 19.21% | +10.33% |
DVSMX vs. NCLEX - Expense Ratio Comparison
DVSMX has a 0.99% expense ratio, which is higher than NCLEX's 0.85% expense ratio.
Dividends
DVSMX vs. NCLEX - Dividend Comparison
DVSMX's dividend yield for the trailing twelve months is around 0.17%, less than NCLEX's 7.97% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
DVSMX Driehaus Small Cap Growth Fund | 0.17% | 0.21% | 1.08% | 0.38% | 2.15% | 17.58% | 6.55% | 6.34% | 2.87% | 0.00% | 0.00% | 0.00% |
NCLEX Nicholas Limited Edition Fund | 7.97% | 7.53% | 2.51% | 2.43% | 6.22% | 16.44% | 5.10% | 5.66% | 10.72% | 7.97% | 10.68% | 8.05% |
Frequently Asked Questions
DVSMX and NCLEX have a correlation of 0.54, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
DVSMX has higher volatility (10.33%) compared to NCLEX (4.88%). In terms of maximum drawdown, DVSMX dropped -47.64% vs NCLEX's -48.68%.
DVSMX currently has the higher Sharpe Ratio (1.93 vs -0.67), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for DVSMX and NCLEX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer